BioDelivery Sciences Articles
BioDelivery Sciences set to file for Suboxone copy drug 2nd-qtr 2013
17 September 2012
Endo Pharma in $180 million deal with BioDelivery Sciences
8 January 2012
Showing 1-4 of 4 articles
- 1
- FDA probes two deaths possibly linked to Lilly's antipsychotic Zyprexa Relprevv
- Negative US patent ruling for Novo Nordisk on Prandin
- Aspen Pharma offers to buy GlaxoSmithKline's thrombosis brands and manufacturing site
- US Supreme Court says patent settlement can "sometimes" be illegal
- Daiichi Sankyo files for Japanese approval of Prasugrel
